118 related articles for article (PubMed ID: 9609614)
21. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens.
Chen S; Zheng Y; Chen B; Zhong H; Liao F; Wang L; Hui SF; Lai X
Int Arch Allergy Immunol; 2019; 178(2):201-210. PubMed ID: 30544116
[TBL] [Abstract][Full Text] [Related]
22. The change of allergen-specific IgG subclass antibodies during immunotherapy in mite-sensitive asthmatic children.
Wang JY; Lei HY; Hsieh KH
Asian Pac J Allergy Immunol; 1992 Jun; 10(1):11-8. PubMed ID: 1418178
[TBL] [Abstract][Full Text] [Related]
23. [The investigation of asthmatic children by multiple factor analysis. II. The influence of 17 allergic factors on atopic dermatitis and allergic rhinitis in asthmatic children].
Koya N; Suzuki S; Hara M; Tateno A; Saito S; Nakazato E
Arerugi; 1989 Nov; 38(11):1255-67. PubMed ID: 2627160
[TBL] [Abstract][Full Text] [Related]
24. IgG4 antibodies in patients with house-dust-mite-sensitive bronchial asthma: relationship with antigen-specific immunotherapy.
Nakagawa T; Takaishi T; Sakamoto Y; Ito K; Miyamoto T; Skvaril F
Int Arch Allergy Appl Immunol; 1983; 71(2):122-5. PubMed ID: 6188704
[TBL] [Abstract][Full Text] [Related]
25. IgG subclass antibodies in response to house dust mite immunotherapy.
Nakagawa T
N Engl Reg Allergy Proc; 1987; 8(6):423-8. PubMed ID: 3481430
[TBL] [Abstract][Full Text] [Related]
26. Mite-specific induction of interleukin-2 receptor on T lymphocytes from children with mite-sensitive asthma: modified immune response with immunotherapy.
Bonno M; Fujisawa T; Iguchi K; Uchida Y; Kamiya H; Komada Y; Sakurai M
J Allergy Clin Immunol; 1996 Feb; 97(2):680-8. PubMed ID: 8621854
[TBL] [Abstract][Full Text] [Related]
27. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of rapid injection immunotherapy by antigen specific IgE and IgG4 antibodies].
Satoh Y; Sugimoto K; Kuroki H; Fuzimoto N; Suzuki H
Arerugi; 1989 Mar; 38(3):246-53. PubMed ID: 2751431
[TBL] [Abstract][Full Text] [Related]
29. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
[TBL] [Abstract][Full Text] [Related]
30. Mite antigen-induced IL-4 and IL-13 production by basophils derived from atopic asthma patients.
Shimizu Y; Shichijo M; Hiramatsu K; Takeuchi M; Nagai H; Takagi K
Clin Exp Allergy; 1998 Apr; 28(4):497-503. PubMed ID: 9641578
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
32. Administration of interleukin-12 prevents mite Der p 1 allergen-IgE antibody production and airway eosinophil infiltration in an animal model of airway inflammation.
Lee YL; Fu CL; Ye YL; Chiang BL
Scand J Immunol; 1999 Mar; 49(3):229-36. PubMed ID: 10102639
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
Mungan D; Misirligil Z; Gürbüz L
Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy in children with allergic asthma: effect on bronchial hyperreactivity and pharmacotherapy.
Hedlin G; Wille S; Browaldh L; Hildebrand H; Holmgren D; Lindfors A; Nordvall SL; Lowenstein H
J Allergy Clin Immunol; 1999 Apr; 103(4):609-14. PubMed ID: 10200009
[TBL] [Abstract][Full Text] [Related]
35. House dust mite-specific IgE, IgG1, and IgG4 antibodies in patients with perennial rhinitis.
Ohashi Y; Nakai Y; Kihara S; Nakagawa T; Miyamoto T
Ann Otol Rhinol Laryngol; 1987; 96(4):434-7. PubMed ID: 3619289
[TBL] [Abstract][Full Text] [Related]
36. Effect of rush immunotherapy in house-dust-mite (HDM)-sensitive adult bronchial asthma: changes in in vivo and in vitro responses to HDM.
Nagata M; Yamamoto H; Tabe K; Kimura I; Houya I; Kuramitsu K; Kiuchi H; Yanagihara Y; Sakamoto Y; Yamamoto K
Intern Med; 1993 Sep; 32(9):702-9. PubMed ID: 8142674
[TBL] [Abstract][Full Text] [Related]
37. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
Suárez-Fueyo A; Ramos T; Galán A; Jimeno L; Wurtzen PA; Marin A; de Frutos C; Blanco C; Carrera AC; Barber D; Varona R
J Allergy Clin Immunol; 2014 Jan; 133(1):130-8.e1-2. PubMed ID: 24290282
[TBL] [Abstract][Full Text] [Related]
38. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.
Schubert R; Eickmeier O; Garn H; Baer PC; Mueller T; Schulze J; Rose MA; Rosewich M; Renz H; Zielen S
Int Arch Allergy Immunol; 2009; 148(3):251-60. PubMed ID: 18849616
[TBL] [Abstract][Full Text] [Related]
39. Effect of mite allergen immunotherapy on the altered phenotype of dendritic cells in allergic asthmatic children.
Wang CM; Chuang JJ
Ann Allergy Asthma Immunol; 2013 Feb; 110(2):107-12. PubMed ID: 23352530
[TBL] [Abstract][Full Text] [Related]
40. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study.
Platts-Mills T; Vaughan J; Squillace S; Woodfolk J; Sporik R
Lancet; 2001 Mar; 357(9258):752-6. PubMed ID: 11253969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
